MFIM
MBII

Mesirow Financial Investment Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Mesirow Financial Investment Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,618
Closed -$14K – 142
2021
Q1 		$14K Buy
6,618
+2,836
+75% +$5.89K 0.04% 112
2020
Q4 		$4.73K Buy
+3,782
New +$4.51K 0.02% 122

Other funds holding MBII

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Mesirow Financial Investment Management's MBII Position: Q2 2021 in Review

Mesirow Financial Investment Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2021, closing a stake of 6,618 shares — an estimated $14K sold.

Mesirow Financial Investment Management first reported a position in MBII in Q4 2020 and held it in 2 quarters. The position peaked at $14K in Q1 2021. 72 funds tracked by Wall St. Rank hold MBII as of Q2 2021.

  • Mesirow Financial Investment Management reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2021 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 6,618 Marrone Bio Innovations, Inc. shares in Q2 2021, an estimated $14K.
  • Mesirow Financial Investment Management first reported a position in Marrone Bio Innovations, Inc. in Q4 2020 and held it in 2 quarters.
  • Mesirow Financial Investment Management's Marrone Bio Innovations, Inc. position peaked at $14K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2021.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2021, filed 23 Jul 2021.